Advertisement
Research Article Free access | 10.1172/JCI103016
aChemotherapy Service, Memorial Center, and the Division of Experimental Chemotherapy, Sloan-Kettering Institute, New York, N. Y.
1This investigation was supported by research grants from the American Cancer Society, the Damon Runyon Memorial Fund for Cancer Research, the Lasker Foundation and the Grant Foundation, and by Grant C-1889 from the National Cancer Institute of the National Institutes of Health of the United States Public Health Service.
2We wish to express our appreciation to Dr. George H. Hitchings of the Wellcome Research Laboratories for the supply of DDMP and the Lederle Laboratories Division of the American Cyanamid Company for the supply of Leucovorin.
Find articles by Murphy, M. in: JCI | PubMed | Google Scholar
aChemotherapy Service, Memorial Center, and the Division of Experimental Chemotherapy, Sloan-Kettering Institute, New York, N. Y.
1This investigation was supported by research grants from the American Cancer Society, the Damon Runyon Memorial Fund for Cancer Research, the Lasker Foundation and the Grant Foundation, and by Grant C-1889 from the National Cancer Institute of the National Institutes of Health of the United States Public Health Service.
2We wish to express our appreciation to Dr. George H. Hitchings of the Wellcome Research Laboratories for the supply of DDMP and the Lederle Laboratories Division of the American Cyanamid Company for the supply of Leucovorin.
Find articles by Ellison, R. in: JCI | PubMed | Google Scholar
aChemotherapy Service, Memorial Center, and the Division of Experimental Chemotherapy, Sloan-Kettering Institute, New York, N. Y.
1This investigation was supported by research grants from the American Cancer Society, the Damon Runyon Memorial Fund for Cancer Research, the Lasker Foundation and the Grant Foundation, and by Grant C-1889 from the National Cancer Institute of the National Institutes of Health of the United States Public Health Service.
2We wish to express our appreciation to Dr. George H. Hitchings of the Wellcome Research Laboratories for the supply of DDMP and the Lederle Laboratories Division of the American Cyanamid Company for the supply of Leucovorin.
Find articles by Karnofsky, D. in: JCI | PubMed | Google Scholar
aChemotherapy Service, Memorial Center, and the Division of Experimental Chemotherapy, Sloan-Kettering Institute, New York, N. Y.
1This investigation was supported by research grants from the American Cancer Society, the Damon Runyon Memorial Fund for Cancer Research, the Lasker Foundation and the Grant Foundation, and by Grant C-1889 from the National Cancer Institute of the National Institutes of Health of the United States Public Health Service.
2We wish to express our appreciation to Dr. George H. Hitchings of the Wellcome Research Laboratories for the supply of DDMP and the Lederle Laboratories Division of the American Cyanamid Company for the supply of Leucovorin.
Find articles by Burchenal, J. in: JCI | PubMed | Google Scholar
Published October 1, 1954 - More info